CLINICAL NUTRITION, vol.33, no.5, pp.815-822, 2014 (Journal Indexed in SCI)
Article / Article
Title of Journal :
Apolipoprotein A-I, Coronary heart disease risk, HDL-cholesterol, Metabolic syndrome, Phospholipids, Population-based study, METABOLIC SYNDROME, OXIDIZED PHOSPHOLIPIDS, HDL, ACID, ATHEROGENESIS, INFLAMMATION, DYSFUNCTION
Objective: Given that serum phospholipids (PL) may serve as inflammation mediators, we studied whether they predicted metabolic syndrome (MetS), type-2 diabetes or coronary heart disease (CHD) risk in people prone to enhanced low-grade inflammation.